BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20949451)

  • 21. The FocalPoint System: FocalPoint slide profiler and FocalPoint GS.
    Kardos TF
    Cancer; 2004 Dec; 102(6):334-9. PubMed ID: 15549692
    [No Abstract]   [Full Text] [Related]  

  • 22. BD focalpoint slide profiler performance with atypical glandular cells on SurePath Papanicolaou smears.
    Chute DJ; Lim H; Kong CS
    Cancer Cytopathol; 2010 Apr; 118(2):68-74. PubMed ID: 20209621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the performance of rapid prescreening, 10% random review, and clinical risk criteria as methods of internal quality control in cervical cytopathology.
    Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
    Cancer; 2008 Jun; 114(3):165-70. PubMed ID: 18454462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Location-guided screening of liquid-based cervical cytology specimens: a potential improvement in accuracy and productivity is demonstrated in a preclinical feasibility trial.
    Wilbur DC; Parker EM; Foti JA
    Am J Clin Pathol; 2002 Sep; 118(3):399-407. PubMed ID: 12219782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
    Linder J; Zahniser D
    Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance and reproducibility of gynecologic cytology interpretation using the FocalPoint system: results of the RODEO Study Team.
    Stein MD; Fregnani JH; Scapulatempo C; Mafra A; Campacci N; Longatto-Filho A;
    Am J Clin Pathol; 2013 Oct; 140(4):567-71. PubMed ID: 24045555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid pre-screening is more sensitive in liquid-based cytology than in conventional smears.
    Dudding N; Renshaw AA; Ellis K
    Acta Cytol; 2011; 55(1):54-6. PubMed ID: 21135523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring the significance of workload on performance of cytotechnologists in gynecologic cytology: a study using rapid prescreening.
    Deschenes M; Renshaw AA; Auger M
    Cancer; 2008 Jun; 114(3):149-54. PubMed ID: 18412150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
    Sherman ME; Schiffman M; Herrero R; Kelly D; Bratti C; Mango LJ; Alfaro M; Hutchinson ML; Mena F; Hildesheim A; Morales J; Greenberg MD; Balmaceda I; Lorincz AT
    Cancer; 1998 Oct; 84(5):273-80. PubMed ID: 9801201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A validation study of the FocalPoint GS imaging system for gynecologic cytology screening.
    Colgan TJ; Bon N; Clipsham S; Gardiner G; Sumner J; Walley V; McLachlin CM
    Cancer Cytopathol; 2013 Apr; 121(4):189-96. PubMed ID: 23361915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality control and automation in cervical cytology.
    Kumar N; Jain S
    J Indian Med Assoc; 2004 Jul; 102(7):372, 374, 376 pasim. PubMed ID: 15717583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting screening sensitivity from workload in gynecologic cytology: a review.
    Renshaw AA; Elsheikh TM
    Diagn Cytopathol; 2011 Nov; 39(11):832-6. PubMed ID: 21994194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for cervical disease in mature women: strategies for improvement.
    Colgan TJ; Clarke A; Hakh N; Seidenfeld A
    Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi.
    Depuydt CE; Benoy IH; Bailleul EJ; Vandepitte J; Vereecken AJ; Bogers JJ
    Cytopathology; 2006 Dec; 17(6):374-81. PubMed ID: 17168921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing cytotechnologist workload above 100 slides per day using the ThinPrep imaging system leads to significant reductions in screening accuracy.
    Elsheikh TM; Kirkpatrick JL; Cooper MK; Johnson ML; Hawkins AP; Renshaw AA
    Cancer Cytopathol; 2010 Apr; 118(2):75-82. PubMed ID: 20151428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.